Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Prevention and management of neutropenic sepsis in patients with cancer: summary of NICE guidance.

Phillips R, Hancock B, Graham J, Bromham N, Jin H, Berendse S.

BMJ. 2012 Sep 19;345:e5368. doi: 10.1136/bmj.e5368. No abstract available.

PMID:
22993392
2.

Neutropenic sepsis: prevention, identification and treatment.

Warnock C.

Nurs Stand. 2016 Apr 27;30(35):51-60. doi: 10.7748/ns.30.35.51.s48.

PMID:
27191320
3.

Do patients with neutropenic sepsis need granulocyte stimulating factor (GCSF)?

Coventry T, Azam F.

Clin Med (Lond). 2016 Jun 1;16 Suppl 3:s8. doi: 10.7861/clinmedicine.16-3-s8. No abstract available.

PMID:
27252345
4.

A reaudit of current febrile neutropenia practice in UK paediatric oncology centres prior to implementation of NICE guidance.

Bate J, Gibson F, Selwood K, Skinner R, Phillips B, Chisholm JC.

Arch Dis Child. 2013 Apr;98(4):315-6. doi: 10.1136/archdischild-2013-303810. Epub 2013 Mar 6. No abstract available.

PMID:
23467661
5.

Role of G-CSF GM-CSF in the management of infections in preterm newborns: an update.

Castagnola E, Dufour C.

Early Hum Dev. 2014 Sep;90 Suppl 2:S15-7. doi: 10.1016/S0378-3782(14)50005-9. Review.

PMID:
25220119
6.

[Bacterial sepsis in the hematologic neutropenic patient].

Todeschini G, Benato G, Carlini S, Veneri D.

Haematologica. 1989 Oct;74(5 Suppl):297-309. Review. Italian. No abstract available.

PMID:
2480272
7.

Neutropenic sepsis: management and complications.

Clarke RT, Jenyon T, van Hamel Parsons V, King AJ.

Clin Med (Lond). 2013 Apr;13(2):185-7. doi: 10.7861/clinmedicine.13-2-185. No abstract available.

PMID:
23681870
8.

Colony-stimulating factors for adjunctive therapy of infections in neutropenic cancer patients.

Mayordomo JI, Rivera F, Cortes-Funes H.

Support Care Cancer. 1995 Jan;3(1):84-5. No abstract available.

PMID:
7535169
9.

Evidence-based recommendations for antimicrobial use in febrile neutropenia in Japan: executive summary.

Masaoka T.

Clin Infect Dis. 2004 Jul 15;39 Suppl 1:S49-52. No abstract available.

PMID:
15250021
10.

[Usefulness of G-CSF in pediatric high risk cancer patients with fever and neutropenia].

Rodríguez Z N, Tordecilla C J, Campbell B M, Joannon S P, Rizzardini L C, Soto A V, Verdugo L P.

Rev Chilena Infectol. 2005 Sep;22(3):223-7. Epub 2005 Aug 2. Spanish.

12.

[Evidence-based management of neutropenia and fever].

Ishiguro H, Fung MC, Sakata T, Morizane T, Adachi S.

Gan To Kagaku Ryoho. 2003 Sep;30(9):1365-71. Review. Japanese.

PMID:
14518423
13.

[Immunoglobulin concentrate and G-CSF].

Yamazaki M, Funada H.

Nihon Rinsho. 2007 Feb 28;65 Suppl 2 Pt. 1:321-5. Review. Japanese. No abstract available.

PMID:
17455639
14.

Recombinant granulocyte colony-stimulating factor (G-CSF) in infectious diseases: still a debate.

Wiedermann FJ, Mittermayr M, Hoffmann G, Schobersberger W.

Wien Klin Wochenschr. 2001 Feb 15;113(3-4):90-6. Review.

PMID:
11253746
15.

Strategies for minimizing complications of neutropenia: prophylactic myeloid growth factors or antibiotics.

Wingard JR, Elmongy M.

Crit Rev Oncol Hematol. 2009 Nov;72(2):144-54. doi: 10.1016/j.critrevonc.2009.01.003. Epub 2009 Feb 23. Review.

PMID:
19237297
16.

EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer.

Repetto L, Biganzoli L, Koehne CH, Luebbe AS, Soubeyran P, Tjan-Heijnen VC, Aapro MS.

Eur J Cancer. 2003 Nov;39(16):2264-72. Review.

PMID:
14556916
17.

[Bone marrow suppression--including guidelines for the appropriate use of G-CSF].

Watanabe T.

Gan To Kagaku Ryoho. 2003 Jun;30(6):755-9. Review. Japanese.

PMID:
12852340
18.

Cefepime vs. Meropenem as empirical therapy for neutropenic fever in children with lymphoma and solid tumours.

Kutluk T, Kurne O, Akyüz C, Ceyhan M, Kanra G, Büyükpamukçu M, Seçmeer G.

Pediatr Blood Cancer. 2004 Mar;42(3):284-6. No abstract available.

PMID:
14752869
19.

Introduction to the Australian consensus guidelines for the management of neutropenic fever in adult cancer patients, 2010/2011. Australian Consensus Guidelines 2011 Steering Committee.

Lingaratnam S, Slavin MA, Koczwara B, Seymour JF, Szer J, Underhill C, Prince M, Mileshkin L, O'Reilly M, Kirsa SW, Bennett CA, Davis ID, Morrissey O, Thursky KA; Australian Consensus Guidelines 2011 Steering Committee.

Intern Med J. 2011 Jan;41(1b):75-81. doi: 10.1111/j.1445-5994.2010.02338.x.

PMID:
21272171
20.

Neutropenic sepsis.

Jones T.

Nurs Stand. 2016 Sep 28;31(5):64-5. doi: 10.7748/ns.31.5.64.s44.

PMID:
27682569

Supplemental Content

Support Center